nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Dactinomycin—testicular cancer	0.414	0.659	CbGbCtD
Cefadroxil—SLC22A8—Methotrexate—testicular cancer	0.126	0.201	CbGbCtD
Cefadroxil—SLC22A6—Methotrexate—testicular cancer	0.088	0.14	CbGbCtD
Cefadroxil—Erythema multiforme—Dactinomycin—testicular cancer	0.00157	0.00423	CcSEcCtD
Cefadroxil—Cramp muscle—Etoposide—testicular cancer	0.00156	0.00421	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.00156	0.00421	CcSEcCtD
Cefadroxil—Pancytopenia—Cisplatin—testicular cancer	0.00156	0.00419	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Etoposide—testicular cancer	0.00153	0.00413	CcSEcCtD
Cefadroxil—Haemoglobin—Ifosfamide—testicular cancer	0.00153	0.00412	CcSEcCtD
Cefadroxil—Haemorrhage—Ifosfamide—testicular cancer	0.00152	0.0041	CcSEcCtD
Cefadroxil—Thrombocytopenia—Vinblastine—testicular cancer	0.00147	0.00395	CcSEcCtD
Cefadroxil—Erythema multiforme—Ifosfamide—testicular cancer	0.00144	0.00387	CcSEcCtD
Cefadroxil—Dyspepsia—Chlorambucil—testicular cancer	0.00144	0.00387	CcSEcCtD
Cefadroxil—Vaginal inflammation—Methotrexate—testicular cancer	0.00143	0.00386	CcSEcCtD
Cefadroxil—Pancytopenia—Etoposide—testicular cancer	0.00143	0.00384	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—testicular cancer	0.00142	0.00382	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00141	0.0038	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—testicular cancer	0.00141	0.0038	CcSEcCtD
Cefadroxil—Neutropenia—Etoposide—testicular cancer	0.0014	0.00378	CcSEcCtD
Cefadroxil—Vaginal infection—Methotrexate—testicular cancer	0.00135	0.00364	CcSEcCtD
Cefadroxil—Aplastic anaemia—Methotrexate—testicular cancer	0.00135	0.00362	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—testicular cancer	0.00134	0.00361	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—testicular cancer	0.00134	0.00361	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00134	0.0036	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00133	0.00357	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—testicular cancer	0.00131	0.00353	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—testicular cancer	0.0013	0.00351	CcSEcCtD
Cefadroxil—Urticaria—Chlorambucil—testicular cancer	0.0013	0.0035	CcSEcCtD
Cefadroxil—Abdominal pain—Chlorambucil—testicular cancer	0.00129	0.00348	CcSEcCtD
Cefadroxil—Body temperature increased—Chlorambucil—testicular cancer	0.00129	0.00348	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—testicular cancer	0.00127	0.00341	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—testicular cancer	0.00127	0.00341	CcSEcCtD
Cefadroxil—Anaphylactic shock—Bleomycin—testicular cancer	0.00126	0.00341	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—testicular cancer	0.00126	0.00339	CcSEcCtD
Cefadroxil—Agranulocytosis—Etoposide—testicular cancer	0.00125	0.00336	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—testicular cancer	0.00124	0.00334	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—testicular cancer	0.00124	0.00334	CcSEcCtD
Cefadroxil—Thrombocytopenia—Bleomycin—testicular cancer	0.00124	0.00334	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vinblastine—testicular cancer	0.00122	0.0033	CcSEcCtD
Cefadroxil—Angioedema—Ifosfamide—testicular cancer	0.00121	0.00326	CcSEcCtD
Cefadroxil—Hypersensitivity—Chlorambucil—testicular cancer	0.0012	0.00324	CcSEcCtD
Cefadroxil—Vertigo—Ifosfamide—testicular cancer	0.00119	0.00321	CcSEcCtD
Cefadroxil—Abdominal pain—Vinblastine—testicular cancer	0.00118	0.00319	CcSEcCtD
Cefadroxil—Asthenia—Chlorambucil—testicular cancer	0.00117	0.00316	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—testicular cancer	0.00117	0.00316	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—testicular cancer	0.00117	0.00316	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—testicular cancer	0.00116	0.00314	CcSEcCtD
Cefadroxil—Hepatic failure—Methotrexate—testicular cancer	0.00116	0.00312	CcSEcCtD
Cefadroxil—Pruritus—Chlorambucil—testicular cancer	0.00116	0.00311	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—testicular cancer	0.00115	0.00311	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00115	0.0031	CcSEcCtD
Cefadroxil—Convulsion—Ifosfamide—testicular cancer	0.00115	0.00309	CcSEcCtD
Cefadroxil—Erythema multiforme—Etoposide—testicular cancer	0.00114	0.00306	CcSEcCtD
Cefadroxil—Arthralgia—Ifosfamide—testicular cancer	0.00113	0.00304	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.00112	0.00302	CcSEcCtD
Cefadroxil—Diarrhoea—Chlorambucil—testicular cancer	0.00112	0.00301	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—testicular cancer	0.00111	0.003	CcSEcCtD
Cefadroxil—Hypersensitivity—Vinblastine—testicular cancer	0.0011	0.00297	CcSEcCtD
Cefadroxil—Muscle spasms—Cisplatin—testicular cancer	0.0011	0.00296	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—testicular cancer	0.00108	0.00292	CcSEcCtD
Cefadroxil—Anaphylactic shock—Ifosfamide—testicular cancer	0.00108	0.00291	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00107	0.00289	CcSEcCtD
Cefadroxil—Asthenia—Vinblastine—testicular cancer	0.00107	0.00289	CcSEcCtD
Cefadroxil—Thrombocytopenia—Ifosfamide—testicular cancer	0.00106	0.00285	CcSEcCtD
Cefadroxil—Vomiting—Chlorambucil—testicular cancer	0.00104	0.0028	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00104	0.00279	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00103	0.00278	CcSEcCtD
Cefadroxil—Diarrhoea—Vinblastine—testicular cancer	0.00102	0.00276	CcSEcCtD
Cefadroxil—Muscle spasms—Etoposide—testicular cancer	0.00101	0.00271	CcSEcCtD
Cefadroxil—Urticaria—Bleomycin—testicular cancer	0.001	0.00271	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—testicular cancer	0.001	0.0027	CcSEcCtD
Cefadroxil—Body temperature increased—Bleomycin—testicular cancer	0.001	0.00269	CcSEcCtD
Cefadroxil—Dizziness—Vinblastine—testicular cancer	0.00099	0.00267	CcSEcCtD
Cefadroxil—Convulsion—Cisplatin—testicular cancer	0.000989	0.00266	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000985	0.00265	CcSEcCtD
Cefadroxil—Nausea—Chlorambucil—testicular cancer	0.00097	0.00261	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000964	0.0026	CcSEcCtD
Cefadroxil—Somnolence—Ifosfamide—testicular cancer	0.000961	0.00259	CcSEcCtD
Cefadroxil—Vomiting—Vinblastine—testicular cancer	0.000952	0.00256	CcSEcCtD
Cefadroxil—Vertigo—Etoposide—testicular cancer	0.00094	0.00253	CcSEcCtD
Cefadroxil—Headache—Vinblastine—testicular cancer	0.000938	0.00253	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000937	0.00252	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000933	0.00251	CcSEcCtD
Cefadroxil—Abdominal pain—Dactinomycin—testicular cancer	0.000932	0.00251	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—testicular cancer	0.000932	0.00251	CcSEcCtD
Cefadroxil—Anaphylactic shock—Cisplatin—testicular cancer	0.000932	0.00251	CcSEcCtD
Cefadroxil—Hypersensitivity—Bleomycin—testicular cancer	0.000932	0.00251	CcSEcCtD
Cefadroxil—Thrombocytopenia—Cisplatin—testicular cancer	0.000912	0.00246	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—testicular cancer	0.000912	0.00246	CcSEcCtD
Cefadroxil—Asthenia—Bleomycin—testicular cancer	0.000907	0.00244	CcSEcCtD
Cefadroxil—Convulsion—Etoposide—testicular cancer	0.000906	0.00244	CcSEcCtD
Cefadroxil—Pruritus—Bleomycin—testicular cancer	0.000895	0.00241	CcSEcCtD
Cefadroxil—Eosinophilia—Methotrexate—testicular cancer	0.00089	0.0024	CcSEcCtD
Cefadroxil—Nausea—Vinblastine—testicular cancer	0.000889	0.0024	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000884	0.00238	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000877	0.00236	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000877	0.00236	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—testicular cancer	0.000869	0.00234	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000859	0.00231	CcSEcCtD
Cefadroxil—Urticaria—Ifosfamide—testicular cancer	0.000859	0.00231	CcSEcCtD
Cefadroxil—Abdominal pain—Ifosfamide—testicular cancer	0.000854	0.0023	CcSEcCtD
Cefadroxil—Body temperature increased—Ifosfamide—testicular cancer	0.000854	0.0023	CcSEcCtD
Cefadroxil—Pancytopenia—Methotrexate—testicular cancer	0.000854	0.0023	CcSEcCtD
Cefadroxil—Anaphylactic shock—Etoposide—testicular cancer	0.000854	0.0023	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000849	0.00229	CcSEcCtD
Cefadroxil—Asthenia—Dactinomycin—testicular cancer	0.000846	0.00228	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—testicular cancer	0.000844	0.00227	CcSEcCtD
Cefadroxil—Neutropenia—Methotrexate—testicular cancer	0.000841	0.00226	CcSEcCtD
Cefadroxil—Thrombocytopenia—Etoposide—testicular cancer	0.000836	0.00225	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—testicular cancer	0.000833	0.00224	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000811	0.00219	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000811	0.00219	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—testicular cancer	0.000807	0.00217	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000804	0.00217	CcSEcCtD
Cefadroxil—Vomiting—Bleomycin—testicular cancer	0.000804	0.00217	CcSEcCtD
Cefadroxil—Drowsiness—Methotrexate—testicular cancer	0.000802	0.00216	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—testicular cancer	0.000799	0.00215	CcSEcCtD
Cefadroxil—Rash—Bleomycin—testicular cancer	0.000797	0.00215	CcSEcCtD
Cefadroxil—Dermatitis—Bleomycin—testicular cancer	0.000797	0.00215	CcSEcCtD
Cefadroxil—Hypersensitivity—Ifosfamide—testicular cancer	0.000796	0.00215	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000795	0.00214	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000794	0.00214	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—testicular cancer	0.000787	0.00212	CcSEcCtD
Cefadroxil—Asthenia—Ifosfamide—testicular cancer	0.000775	0.00209	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—testicular cancer	0.000771	0.00208	CcSEcCtD
Cefadroxil—Pruritus—Ifosfamide—testicular cancer	0.000765	0.00206	CcSEcCtD
Cefadroxil—Somnolence—Etoposide—testicular cancer	0.000759	0.00204	CcSEcCtD
Cefadroxil—Nausea—Bleomycin—testicular cancer	0.000751	0.00202	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—testicular cancer	0.00075	0.00202	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—testicular cancer	0.00075	0.00202	CcSEcCtD
Cefadroxil—Agranulocytosis—Methotrexate—testicular cancer	0.000748	0.00202	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000744	0.002	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—testicular cancer	0.000744	0.002	CcSEcCtD
Cefadroxil—Diarrhoea—Ifosfamide—testicular cancer	0.000739	0.00199	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—testicular cancer	0.000739	0.00199	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Etoposide—testicular cancer	0.000737	0.00199	CcSEcCtD
Cefadroxil—Body temperature increased—Cisplatin—testicular cancer	0.000737	0.00198	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—testicular cancer	0.000728	0.00196	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—testicular cancer	0.000723	0.00195	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—testicular cancer	0.00072	0.00194	CcSEcCtD
Cefadroxil—Dizziness—Ifosfamide—testicular cancer	0.000715	0.00193	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—testicular cancer	0.0007	0.00189	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—testicular cancer	0.0007	0.00189	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Etoposide—testicular cancer	0.000698	0.00188	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—testicular cancer	0.000694	0.00187	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000688	0.00185	CcSEcCtD
Cefadroxil—Vomiting—Ifosfamide—testicular cancer	0.000687	0.00185	CcSEcCtD
Cefadroxil—Hypersensitivity—Cisplatin—testicular cancer	0.000686	0.00185	CcSEcCtD
Cefadroxil—Rash—Ifosfamide—testicular cancer	0.000681	0.00184	CcSEcCtD
Cefadroxil—Dermatitis—Ifosfamide—testicular cancer	0.000681	0.00183	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—testicular cancer	0.00068	0.00183	CcSEcCtD
Cefadroxil—Urticaria—Etoposide—testicular cancer	0.000678	0.00183	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—testicular cancer	0.000677	0.00182	CcSEcCtD
Cefadroxil—Body temperature increased—Etoposide—testicular cancer	0.000675	0.00182	CcSEcCtD
Cefadroxil—Abdominal pain—Etoposide—testicular cancer	0.000675	0.00182	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—testicular cancer	0.000673	0.00181	CcSEcCtD
Cefadroxil—Asthenia—Cisplatin—testicular cancer	0.000668	0.0018	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—testicular cancer	0.000648	0.00175	CcSEcCtD
Cefadroxil—Nausea—Ifosfamide—testicular cancer	0.000642	0.00173	CcSEcCtD
Cefadroxil—Diarrhoea—Cisplatin—testicular cancer	0.000637	0.00172	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—testicular cancer	0.000637	0.00172	CcSEcCtD
Cefadroxil—Hypersensitivity—Etoposide—testicular cancer	0.000629	0.00169	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—testicular cancer	0.000626	0.00169	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—testicular cancer	0.000623	0.00168	CcSEcCtD
Cefadroxil—Asthenia—Etoposide—testicular cancer	0.000612	0.00165	CcSEcCtD
Cefadroxil—Pruritus—Etoposide—testicular cancer	0.000604	0.00163	CcSEcCtD
Cefadroxil—Vomiting—Cisplatin—testicular cancer	0.000592	0.0016	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—testicular cancer	0.000589	0.00159	CcSEcCtD
Cefadroxil—Rash—Cisplatin—testicular cancer	0.000587	0.00158	CcSEcCtD
Cefadroxil—Dermatitis—Cisplatin—testicular cancer	0.000587	0.00158	CcSEcCtD
Cefadroxil—Diarrhoea—Etoposide—testicular cancer	0.000584	0.00157	CcSEcCtD
Cefadroxil—Tension—Epirubicin—testicular cancer	0.000575	0.00155	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—testicular cancer	0.000569	0.00153	CcSEcCtD
Cefadroxil—Dizziness—Etoposide—testicular cancer	0.000564	0.00152	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—testicular cancer	0.000564	0.00152	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—testicular cancer	0.000563	0.00152	CcSEcCtD
Cefadroxil—Nausea—Cisplatin—testicular cancer	0.000553	0.00149	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—testicular cancer	0.000543	0.00146	CcSEcCtD
Cefadroxil—Vomiting—Etoposide—testicular cancer	0.000543	0.00146	CcSEcCtD
Cefadroxil—Rash—Etoposide—testicular cancer	0.000538	0.00145	CcSEcCtD
Cefadroxil—Dermatitis—Etoposide—testicular cancer	0.000538	0.00145	CcSEcCtD
Cefadroxil—Headache—Etoposide—testicular cancer	0.000535	0.00144	CcSEcCtD
Cefadroxil—Arthralgia—Methotrexate—testicular cancer	0.000533	0.00144	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—testicular cancer	0.000532	0.00143	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—testicular cancer	0.000527	0.00142	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—testicular cancer	0.000527	0.00142	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—testicular cancer	0.000522	0.0014	CcSEcCtD
Cefadroxil—Anaphylactic shock—Methotrexate—testicular cancer	0.000511	0.00138	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—testicular cancer	0.000508	0.00137	CcSEcCtD
Cefadroxil—Nausea—Etoposide—testicular cancer	0.000507	0.00137	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—testicular cancer	0.000501	0.00135	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—testicular cancer	0.000499	0.00134	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—testicular cancer	0.000487	0.00131	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—testicular cancer	0.000478	0.00129	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—testicular cancer	0.00047	0.00127	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—testicular cancer	0.000468	0.00126	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000466	0.00125	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—testicular cancer	0.000462	0.00124	CcSEcCtD
Cefadroxil—Somnolence—Methotrexate—testicular cancer	0.000455	0.00122	CcSEcCtD
Cefadroxil—Dyspepsia—Methotrexate—testicular cancer	0.00045	0.00121	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—testicular cancer	0.000443	0.00119	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000441	0.00119	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000436	0.00117	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—testicular cancer	0.000433	0.00117	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—testicular cancer	0.000425	0.00115	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—testicular cancer	0.000421	0.00113	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Methotrexate—testicular cancer	0.000418	0.00113	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000413	0.00111	CcSEcCtD
Cefadroxil—Urticaria—Methotrexate—testicular cancer	0.000406	0.00109	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—testicular cancer	0.000404	0.00109	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—testicular cancer	0.000404	0.00109	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000403	0.00109	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—testicular cancer	0.000394	0.00106	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—testicular cancer	0.000391	0.00105	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—testicular cancer	0.00039	0.00105	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000382	0.00103	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—testicular cancer	0.00038	0.00102	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—testicular cancer	0.000378	0.00102	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—testicular cancer	0.000378	0.00102	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—testicular cancer	0.000377	0.00101	CcSEcCtD
Cefadroxil—Asthenia—Methotrexate—testicular cancer	0.000367	0.000988	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000362	0.000975	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—testicular cancer	0.000362	0.000974	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—testicular cancer	0.000353	0.00095	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—testicular cancer	0.000352	0.000947	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—testicular cancer	0.00035	0.000943	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—testicular cancer	0.00035	0.000943	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—testicular cancer	0.00035	0.000942	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—testicular cancer	0.000343	0.000925	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—testicular cancer	0.000338	0.000912	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—testicular cancer	0.000338	0.000911	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—testicular cancer	0.000327	0.000882	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—testicular cancer	0.000326	0.000879	CcSEcCtD
Cefadroxil—Vomiting—Methotrexate—testicular cancer	0.000325	0.000876	CcSEcCtD
Cefadroxil—Rash—Methotrexate—testicular cancer	0.000322	0.000868	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—testicular cancer	0.000322	0.000868	CcSEcCtD
Cefadroxil—Headache—Methotrexate—testicular cancer	0.00032	0.000863	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—testicular cancer	0.000318	0.000856	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—testicular cancer	0.000316	0.000852	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—testicular cancer	0.000313	0.000844	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—testicular cancer	0.000304	0.00082	CcSEcCtD
Cefadroxil—Nausea—Methotrexate—testicular cancer	0.000304	0.000818	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—testicular cancer	0.000303	0.000816	CcSEcCtD
Cefadroxil—Rash—Epirubicin—testicular cancer	0.000302	0.000813	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—testicular cancer	0.000301	0.000812	CcSEcCtD
Cefadroxil—Headache—Epirubicin—testicular cancer	0.0003	0.000807	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—testicular cancer	0.000293	0.000789	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—testicular cancer	0.000284	0.000766	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—testicular cancer	0.000281	0.000758	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—testicular cancer	0.000279	0.000752	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—testicular cancer	0.000279	0.000751	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—testicular cancer	0.000277	0.000747	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—testicular cancer	0.000263	0.000708	CcSEcCtD
